Published in Dig Dis Sci on August 06, 2010
Over expression of minichromosome maintenance genes is clinically correlated to cervical carcinogenesis. PLoS One (2013) 0.96
MCM Paradox: Abundance of Eukaryotic Replicative Helicases and Genomic Integrity. Mol Biol Int (2014) 0.85
The Expression and Prognostic Roles of MCMs in Pancreatic Cancer. PLoS One (2016) 0.77
Genome wide comparative comprehensive analysis of Plasmodium falciparum MCM family with human host. Commun Integr Biol (2012) 0.76
MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions. Hum Pathol (2016) 0.75
Comparison of the blood and lymphatic microvessel density of pleomorphic adenoma and Basal cell adenoma. Clin Med Insights Pathol (2015) 0.75
Expression of minichromosome maintenance 8 in chronic myelogenous leukemia. Int J Clin Exp Pathol (2015) 0.75
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand (1965) 22.65
MCM proteins in DNA replication. Annu Rev Biochem (1999) 13.88
DNA replication in eukaryotic cells. Annu Rev Biochem (2001) 13.39
Gastric cancer. Lancet (2003) 3.96
Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res (1999) 2.49
Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol (2006) 2.40
DNA replication licensing and human cell proliferation. J Cell Sci (2001) 2.30
A rotary pumping model for helicase function of MCM proteins at a distance from replication forks. EMBO Rep (2003) 1.86
MCM proteins and DNA replication. Curr Opin Cell Biol (2006) 1.81
The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res (2000) 1.81
Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis. J Cell Biol (1988) 1.79
Genetic pathways of two types of gastric cancer. IARC Sci Publ (2004) 1.71
Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients' survival. Dig Dis Sci (2007) 1.64
Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol (2005) 1.48
Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology. J Pathol (2005) 1.44
Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol (2006) 1.38
Eukaryotic DNA replication: from pre-replication complex to initiation complex. Curr Opin Cell Biol (2000) 1.32
The MCM complex: its role in DNA replication and implications for cancer therapy. Curr Cancer Drug Targets (2005) 1.29
p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol (2005) 1.27
MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. Histol Histopathol (2010) 1.12
Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis. Clin Cancer Res (2004) 1.07
Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria. Ann Surg Oncol (2006) 1.06
The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J Pathol (2000) 1.05
Simultaneous staining of exponentially growing versus plateau phase cells with the proliferation-associated antibody Ki-67 and propidium iodide: analysis by flow cytometry. Cell Tissue Kinet (1987) 0.98
Mechanisms restricting DNA replication to once per cell cycle: the role of Cdc6p and ORC. Trends Cell Biol (1997) 0.98
Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity. Dig Dis Sci (2008) 0.97
Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators. Hum Pathol (2005) 0.92
Molecular biology of gastric cancer. Clin Transl Oncol (2007) 0.91
Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy. Laryngoscope (2006) 0.88
Expression and clinical significance of focal adhesion kinase in the two distinct histological types, intestinal and diffuse, of human gastric adenocarcinoma. Pathol Oncol Res (2008) 0.87
Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade. Br J Cancer (2007) 0.87
Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications. Br J Cancer (2007) 0.83
Relevant prognostic factors in gastric cancer. Ann Surg (2000) 0.82
Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases. Int J Dermatol (2007) 0.79
Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance. Gastric Cancer (2008) 0.77
Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Crit Care (2006) 3.17
Real-time ultrasound-guided subclavian vein cannulation versus the landmark method in critical care patients: a prospective randomized study. Crit Care Med (2011) 3.12
Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol (2008) 1.98
Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients' survival. Dig Dis Sci (2007) 1.64
Comparison of monopolar electrocoagulation, bipolar electrocoagulation, Ultracision, and Ligasure. Surg Today (2006) 1.47
Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer (2003) 1.42
DNA repair systems as targets of cadmium toxicity. Toxicol Appl Pharmacol (2006) 1.21
MCM proteins as diagnostic and prognostic tumor markers in the clinical setting. Histol Histopathol (2010) 1.12
Emergency liver resection for combined biliary and vascular injury following laparoscopic cholecystectomy: case report and review of the literature. South Med J (2007) 1.09
Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism. Fundam Clin Pharmacol (2007) 1.03
Cyto-histological correlations in primary, recurrent and metastatic rhabdomyosarcoma: the institut Curie's experience. Diagn Cytopathol (2007) 1.02
Insights on augmenter of liver regeneration cloning and function. World J Gastroenterol (2006) 1.01
Clinical significance of ephrin (eph)-A1, -A2, -a4, -a5 and -a7 receptors in pancreatic ductal adenocarcinoma. Pathol Oncol Res (2009) 1.00
Primary hydatid disease of the gallbladder: a rare clinical entity. J Hepatobiliary Pancreat Surg (2004) 1.00
Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations. Int J Dermatol (2011) 1.00
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands as potential therapeutic agents to treat arthritis. Pharmacol Res (2009) 0.98
An extended retroperitoneal abscess caused by duodenal diverticulum perforation: report of a case and short review of the literature. Am Surg (2007) 0.97
Local and systemic toxicity of nanoscale debris particles in total hip arthroplasty. J Appl Toxicol (2012) 0.97
Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity. Dig Dis Sci (2008) 0.97
Zinc and the liver: an active interaction. Dig Dis Sci (2007) 0.95
The combined evaluation of p27Kip1 and Ki-67 expression provides independent information on overall survival of ovarian carcinoma patients. Gynecol Oncol (2002) 0.93
MAPKs and NF-κB differentially regulate cytokine expression in the diaphragm in response to resistive breathing: the role of oxidative stress. Am J Physiol Regul Integr Comp Physiol (2011) 0.93
Heat Shock Protein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survival. BMC Gastroenterol (2009) 0.92
Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival. Med Sci Monit (2009) 0.92
1H NMR-based metabonomics approach in a rat model of acute liver injury and regeneration induced by CCl4 administration. Toxicology (2012) 0.91
Clinical implication of plasma neutrophil gelatinase-associated lipocalin (NGAL) concentrations in patients with advanced carotid atherosclerosis. Clin Chem Lab Med (2010) 0.91
Correlation of Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) and Retinoid X Receptor-alpha (RXR-alpha) expression with clinical risk factors in patients with advanced carotid atherosclerosis. Med Sci Monit (2011) 0.91
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury. Curr Mol Med (2008) 0.91
Does the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma? Dig Dis Sci (2008) 0.90
Clinical significance of tumor-associated antigen RCAS1 expression in human pancreatic ductal adenocarcinoma. Dig Dis Sci (2008) 0.90
Effects of exercise training on the severity and composition of atherosclerotic plaque in apoE-deficient mice. J Vasc Res (2011) 0.90
NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links. Expert Opin Ther Targets (2014) 0.89
Toll-like receptors in liver ischemia reperfusion injury: a novel target for therapeutic modulation? Expert Opin Ther Targets (2009) 0.89
Peroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis. Expert Opin Investig Drugs (2007) 0.89
Investigation of the lipophilic behaviour of some thiazolidinediones. Relationships with PPAR-gamma activity. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.87
Histone deacetylase inhibitors and pancreatic cancer: are there any promising clinical trials? World J Gastroenterol (2013) 0.86
Current evidence on the anticancer potential of Chios mastic gum. Nutr Cancer (2011) 0.86
Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer. PPAR Res (2008) 0.85
Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions. Tumour Biol (2013) 0.85
The role of matrix metalloproteinases in the pathophysiology and progression of human nervous system malignancies: a chance for the development of targeted therapeutic approaches? Expert Opin Ther Targets (2008) 0.85
Optimization of Cannula Visibility during Ultrasound-Guided Subclavian Vein Catheterization, via a Longitudinal Approach, by Implementing Echogenic Technology. Crit Care Res Pract (2012) 0.85
Current clinical status on the preventive effects of cranberry consumption against urinary tract infections. Nutr Res (2013) 0.85
Clinical significance of HuR expression in human malignancy. Med Oncol (2014) 0.84
Quantitative structure-activity relationship (QSAR) methodology in forensic toxicology: modeling postmortem redistribution of structurally diverse drugs using multivariate statistics. Forensic Sci Int (2009) 0.84
Multi-targeted molecular therapeutic approach in aggressive neuroblastoma: the effect of Focal Adhesion Kinase-Src-Paxillin system. Expert Opin Ther Targets (2014) 0.84
Current evidence for histone deacetylase inhibitors in pancreatic cancer. World J Gastroenterol (2013) 0.84
Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival. J Oral Pathol Med (2010) 0.84
Ghrelin, another factor affecting bone metabolism. Med Sci Monit (2010) 0.84
Serum tissue inhibitor of metalloproteinase 1 and 2 (TIMP-1 and TIMP-2) levels in colorectal cancer patients: associations with clinicopathological variables and patient survival. Int J Biol Markers (2010) 0.83
Pregnane X receptor (PXR) at the crossroads of human metabolism and disease. Curr Drug Metab (2013) 0.83
Prognostic and predictive value of thymidylate synthase expression in colon cancer. Dig Dis Sci (2007) 0.83
The role of peroxisome proliferator-activated receptor-γ in breast cancer. Anticancer Agents Med Chem (2012) 0.83
Individual patient data systematic review and meta-analysis of optic nerve sheath diameter ultrasonography for detecting raised intracranial pressure: protocol of the ONSD research group. Syst Rev (2013) 0.83
Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival. Pathol Oncol Res (2012) 0.83
Evaluation of FAK and Src expression in human benign and malignant thyroid lesions. Pathol Oncol Res (2010) 0.83
Primary liver tumors: origin and target therapy. Expert Opin Ther Targets (2009) 0.83
Diagnostic and prognostic utility of serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) levels in colon cancer patients. Int J Biol Markers (2009) 0.82
Management of the airway without the use of neuromuscular blocking agents: the use of remifentanil. Fundam Clin Pharmacol (2011) 0.82
Evaluation of coxsackievirus and adenovirus receptor expression in human benign and malignant thyroid lesions. APMIS (2010) 0.82
An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study. BMC Gastroenterol (2007) 0.82
Expression of DNA repair proteins MSH2, MLH1 and MGMT in human benign and malignant thyroid lesions: an immunohistochemical study. Med Sci Monit (2011) 0.82
Toll-like receptor 4 immunohistochemical expression is enhanced in macrophages of symptomatic carotid atherosclerotic plaques. Cerebrovasc Dis (2010) 0.82
Proteasome inhibitors: possible novel therapeutic strategy for ischemia-reperfusion injury? Expert Opin Investig Drugs (2013) 0.82
Effects of fulminant hepatic encephalopathy on the adult rat brain antioxidant status and the activities of acetylcholinesterase, (Na(+),K (+))- and Mg (2+)-ATPase: comparison of the enzymes' response to in vitro treatment with ammonia. Metab Brain Dis (2008) 0.81
Matrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: could their inhibition be an effective therapeutic approach? Expert Opin Ther Targets (2009) 0.81
Anatomical landmarks: dimensions of the mastoid air cell system in the Mediterranean population. Our experience from the anatomy of 298 temporal bones. Anat Sci Int (2007) 0.81
Involvement of hepatic stimulator substance in experimentally induced fibrosis and cirrhosis in the rat. Dig Dis Sci (2008) 0.81
Menetrier disease of early infancy: a separate entity? J Pediatr Gastroenterol Nutr (2004) 0.81
Circadian variation in expression of G1 phase cyclins D1 and E and cyclin-dependent kinase inhibitors p16 and p21 in human bowel mucosa. World J Gastroenterol (2006) 0.81
The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients. Exp Hematol Oncol (2014) 0.81
Peroxisome proliferator-activated receptor-γ in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. J Cancer Res Clin Oncol (2011) 0.81
Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: an immunohistochemical study. Med Sci Monit (2011) 0.80
Effects of short-term exposure to manganese on the adult rat brain antioxidant status and the activities of acetylcholinesterase, (Na,K)-ATPase and Mg-ATPase: modulation by L-cysteine. Basic Clin Pharmacol Toxicol (2008) 0.80
An epitome of DNA repair related genes and mechanisms in thyroid carcinoma. Cancer Lett (2009) 0.80
Farnesoid X Receptor (FXR) from normal to malignant state. Histol Histopathol (2012) 0.80
Fine-needle aspiration in desmoplastic small round cell tumor: a report of 10 new tumors in 8 patients with clinicopathological and molecular correlations with review of the literature. Cancer Cytopathol (2014) 0.80
Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in human benign and malignant thyroid lesions. Med Sci Monit (2012) 0.80
A consideration of PPAR-gamma ligands with respect to lipophilicity: current trends and perspectives. Expert Opin Investig Drugs (2007) 0.80
Hu-antigen receptor (HuR) and cyclooxygenase-2 (COX-2) expression in human non-small-cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival. Tumour Biol (2014) 0.80
Toll-like receptor modulation: a novel therapeutic strategy in cardiovascular disease? Expert Opin Ther Targets (2008) 0.79
Platelet-activating factor involvement in thioacetamide-induced experimental liver fibrosis and cirrhosis. Dig Dis Sci (2009) 0.79
Risk factors for acute adverse events during ultrasound-guided central venous cannulation in the emergency department. Acad Emerg Med (2011) 0.79